/Companies

HISHOH Biopharma㈱

Tokyo, JP · 2 known investors

Find your way into HISHOH Biopharma㈱

Sign up to see every warm intro you have to HISHOH Biopharma㈱

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the HISHOH Biopharma㈱ team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

HISHOH Biopharma develops and commercializes pharmaceutical compounds using proprietary drug discovery technology, supported by a team with extensive R&D experience from Japanese pharmaceutical companies and supported by venture capital investors.

Founders & leadership

NSNaoki Sakurai
Naoki SakuraiRepresentative Director & PresidentNaoki Sakurai has approximately 30 years of pharmaceutical industry experience in managerial and research roles across Japan and the USA, including positions overseeing biologics and small molecule drug development programs, strategic partnerships with institutions such as UC San Diego and pharmaceutical companies, and leadership of Tanabe Research Labs' San Diego operations at Mitsubishi Tanabe Pharma.
TSToru Seo
Toru SeoDirector / Chief Business Development Officer
JHJoji Hayashida
Joji HayashidaDirector / Chief Operating Officer

Board

林丞
林田 丞児

Investors · 2

Frequently asked questions

What does HISHOH Biopharma㈱ do?
HISHOH Biopharma develops and commercializes pharmaceutical compounds using proprietary drug discovery technology, supported by a team with extensive R&D experience from Japanese pharmaceutical companies and supported by venture capital investors.
Who are HISHOH Biopharma㈱'s investors?
HISHOH Biopharma㈱'s investors include DBJ Capital, Mitsubishi UFJ Capital.
Where is HISHOH Biopharma㈱ headquartered?
HISHOH Biopharma㈱ is headquartered in Tokyo, JP.